RU2410386C2 - Novel compounds possessing antibacterial activity - Google Patents
Novel compounds possessing antibacterial activity Download PDFInfo
- Publication number
- RU2410386C2 RU2410386C2 RU2007105995/04A RU2007105995A RU2410386C2 RU 2410386 C2 RU2410386 C2 RU 2410386C2 RU 2007105995/04 A RU2007105995/04 A RU 2007105995/04A RU 2007105995 A RU2007105995 A RU 2007105995A RU 2410386 C2 RU2410386 C2 RU 2410386C2
- Authority
- RU
- Russia
- Prior art keywords
- group
- formula
- compounds
- halogen
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel antibacterial compounds of formula (I). Compounds of formula (I) Q-NH-CO-R3, where Q stands for group of the following structure , R1 represents hydrogen, halogen, hydroxy, amino, mercapto, alkyl, heteroalkyl, alkeloxy, heteroalkyloxy, cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, cycloalkyloxy, alkylcycloalkyloxy, heterocycloalkyloxy or heteroalkylcycloalkyloxy, X1, X2, X3, X4, X5 and X6 each independently on each other represent nitrogen atom or group of formula CR2, R2 represents hydrogen, halogen or hydroxy, amino, alkyl, alkenyl, alkinyl or heteroalkyl group, R3 is selected from the following groups R5 represents group of formula -B-Y, where B represents alkylene, alkenylene, alkinylene, -NH- or heteroalkylene, and Y represents aryl, heteroaryl, aralkyl, heteroaralkyl, cycloalkyl, heterocycloalkyl, alkylcycloalkyl or heteroalkylcycloalkyl, or their pharmaceutically acceptable salt, solvate, hydrate or pharmaceutically acceptable composition, as well as to pharmaceutical composition, which possesses antibacterial activity, based on said compounds and to their application for preparation of medication, intended for treatment of bacterial infections.
EFFECT: obtained and described are compounds, which can be useful in medicine.
9 cl, 147 ex
Description
Claims (9)
где Q означает группу следующей структуры:
R1 означает водород, галоген, гидрокси, амино, меркапто, алкил, гетероалкил, алкилокси, гетероалкилокси, циклоалкил, гетероциклоалкил, алкилциклоалкил, гетероалкилциклоалкил, циклоалкилокси, алкилциклоалкилокси, гетероциклоалкилокси или гетероадкилциклоалкилокси,
X1, X2, X3, X4, X5 и X6 каждый независимо друг от друга означает атом азота или группу формулы CR2,
R2 означает водород, галоген или гидрокси, амино, алкильную, алкенильную, алкинильную или гетероалкильную группу,
R3 выбран из следующих групп:
R5 означает группу формулы -B-Y, где В означает алкилен, алкенилен, алкинилен, -NH- или гетероалкилен, a Y означает арил, гетероарил, аралкил, гетероаралкил, циклоалкил, гетероциклоалкил, алкилциклоалкил или гетероалкилциклоалкил,
или их фармацевтически приемлемая соль, сольват, гидрат или фармацевтически приемлемая композиция.1. The compounds of formula (I)
where Q means a group of the following structure:
R 1 means hydrogen, halogen, hydroxy, amino, mercapto, alkyl, heteroalkyl, alkyloxy, heteroalkyloxy, cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, cycloalkyloxy, alkylcycloalkyloxy, heterocycloalkyloxy or heteroalkylcycloalkyl
X 1 , X 2 , X 3 , X 4 , X 5 and X 6 each independently of one another means a nitrogen atom or a group of the formula CR 2 ,
R 2 means hydrogen, halogen or hydroxy, amino, alkyl, alkenyl, alkynyl or heteroalkyl group,
R 3 is selected from the following groups:
R 5 means a group of formula —BY, where B is alkylene, alkenylene, alkynylene, —NH— or heteroalkylene, and Y is aryl, heteroaryl, aralkyl, heteroaralkyl, cycloalkyl, heterocycloalkyl, alkylcycloalkyl or heteroalkylcycloalkyl,
or a pharmaceutically acceptable salt, solvate, hydrate or pharmaceutically acceptable composition thereof.
2. The compound according to claim 1, where Q is selected from the following groups:
-CH2NHCH2-, -NHCH2CH2-, -NH-, -CH2NHCH2CH2-, -СН2СО- или -NHCH2-.5. The compounds of claims 1 to 4, where B is a group of the formula —CH 2 CH (OH) -,
-CH 2 NHCH 2 -, -NHCH 2 CH 2 -, -NH-, -CH 2 NHCH 2 CH 2 -, -CH 2 CO- or -NHCH 2 -.
или или или
или или или
или или или
или или
где X7, X8 и X9 каждый независимо друг от друга означает атом азота или группу формулы CR21, X10 и X11 каждый независимо друг от друга означает атом кислорода или серы или группу формулы NR22, о равно 0, 1 или 2, R15, R16, R17, R18, R20 и R21 каждый независимо друг от друга означает водород, галоген, гидрокси, алкил, алкенил, алкинил или гетероалкил и R19 и R22 каждый независимо друг от друга означает водород, алкил, алкенил, алкинил или гетероалкил.6. Compounds according to claims 1-5, where Y means one of the following structures:
or or or
or or or
or or or
or or
where X 7 , X 8 and X 9 each independently from each other means a nitrogen atom or a group of formula CR 21 , X 10 and X 11 each independently from each other means an oxygen or sulfur atom or a group of formula NR 22 , o is 0, 1 or 2, R 15 , R 16 , R 17 , R 18 , R 20 and R 21 each independently of each other means hydrogen, halogen, hydroxy, alkyl, alkenyl, alkynyl or heteroalkyl and R 19 and R 22 each independently of one another hydrogen, alkyl, alkenyl, alkynyl or heteroalkyl.
или или
или или
или или
или или 7. Compounds according to claims 1-5, where Y means one of the following structures:
or or
or or
or or
or or
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004041163.8 | 2004-08-25 | ||
DE102004041163A DE102004041163A1 (en) | 2004-08-25 | 2004-08-25 | New compounds with antibacterial activity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2007105995A RU2007105995A (en) | 2008-10-10 |
RU2410386C2 true RU2410386C2 (en) | 2011-01-27 |
Family
ID=35431960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007105995/04A RU2410386C2 (en) | 2004-08-25 | 2005-08-25 | Novel compounds possessing antibacterial activity |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070244103A1 (en) |
EP (1) | EP1781650A1 (en) |
JP (1) | JP2008510762A (en) |
KR (1) | KR20070045152A (en) |
CN (1) | CN101035785A (en) |
AU (1) | AU2005276576A1 (en) |
BR (1) | BRPI0514665A2 (en) |
CA (1) | CA2571132A1 (en) |
DE (1) | DE102004041163A1 (en) |
IL (1) | IL179837A0 (en) |
MX (1) | MX2007002097A (en) |
NZ (1) | NZ552036A (en) |
RU (1) | RU2410386C2 (en) |
WO (1) | WO2006021448A1 (en) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1796466A4 (en) | 2004-06-15 | 2009-09-02 | Glaxo Group Ltd | Antibacterial agents |
JP4887297B2 (en) * | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | New bicyclic antibiotics |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
KR20080064953A (en) * | 2005-10-13 | 2008-07-10 | 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 | Antibacterial active 5-quinoline derivative |
EP1790342A1 (en) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazine derivatives and their use as signal transduction modulators |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
UY30183A1 (en) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | QUINOLINE DERIVATIVES |
WO2007115947A1 (en) | 2006-04-06 | 2007-10-18 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
GB0608263D0 (en) * | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
CL2007003693A1 (en) | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM PIRIDO [3,2-B] [1,4] THIAZINE; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF BACTERIAL INFECTIONS. |
CL2008001003A1 (en) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. |
AU2008240764C1 (en) * | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
EP2182950B8 (en) * | 2007-05-17 | 2017-08-23 | Helperby Therapeutics Limited | Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
ATE520687T1 (en) * | 2007-06-15 | 2011-09-15 | Actelion Pharmaceuticals Ltd | 3-AMINO-6-(1-AMINO-ETHYL)-TETRAHYDROPYRANDERIVA E |
EP2245028B1 (en) | 2007-12-18 | 2012-02-22 | Actelion Pharmaceuticals Ltd. | 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
BRPI0906598A2 (en) | 2008-02-01 | 2015-07-07 | Takeda Pharmaceutical | Oxim derivatives as hsp90 inhibitors |
MX2010008922A (en) | 2008-02-20 | 2010-09-07 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds. |
TW200944529A (en) | 2008-04-15 | 2009-11-01 | Actelion Pharmaceuticals Ltd | Tricyclic antibiotics |
BRPI0920895A8 (en) | 2008-10-07 | 2017-12-26 | Actelion Pharmaceuticals Ltd | TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS |
WO2010043714A1 (en) | 2008-10-17 | 2010-04-22 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
EP2379554B1 (en) | 2009-01-15 | 2015-11-11 | Glaxo Group Limited | Naphthyridin-2(1h)-one compounds useful as antibacterials |
CN102361863B (en) * | 2009-01-21 | 2014-12-03 | 巴斯利尔药物股份公司 | Novel bicyclic antibiotics |
EP2332939A1 (en) | 2009-11-26 | 2011-06-15 | Æterna Zentaris GmbH | Novel Naphthyridine derivatives and the use thereof as kinase inhibitors |
JP5697685B2 (en) | 2009-12-18 | 2015-04-08 | バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG | Tricyclic antibiotics |
ES2596369T3 (en) | 2011-06-17 | 2017-01-09 | Basilea Pharmaceutica Ag | N-heterotricyclic antibiotics |
JP2014533747A (en) | 2011-11-30 | 2014-12-15 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | 3,7-Disubstituted octahydro-2H-pyrido [4,3-e] [1,3] oxazin-2-one antibiotic |
AR090844A1 (en) * | 2012-04-27 | 2014-12-10 | Actelion Pharmaceuticals Ltd | PROCESS TO MANUFACTURE DERIVATIVES OF NAFTIRIDINE |
CN104803913B (en) * | 2014-01-24 | 2019-02-12 | 浙江省化工研究院有限公司 | A kind of carbonic acid benzylquinolin base ester type compound, preparation method and application |
EA031589B1 (en) | 2014-08-22 | 2019-01-31 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
MA41168A (en) | 2014-12-17 | 2017-10-24 | Acraf | NEW ANTIBACTERIAL COMPOUNDS |
MA41169A (en) | 2014-12-17 | 2017-10-24 | Acraf | WIDE-SPECTRUM ANTIBACTERIAL COMPOUNDS |
UY36851A (en) * | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS |
HUE049547T2 (en) | 2016-06-08 | 2020-10-28 | Acraf | New antibacterial compounds |
CN109311897B (en) | 2017-03-20 | 2021-07-20 | 福马治疗股份有限公司 | Pyrrolopyrrole compositions as Pyruvate Kinase (PKR) activators |
US20230055923A1 (en) | 2018-09-19 | 2023-02-23 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
US11691971B2 (en) | 2020-06-19 | 2023-07-04 | Incyte Corporation | Naphthyridinone compounds as JAK2 V617F inhibitors |
US11753413B2 (en) | 2020-06-19 | 2023-09-12 | Incyte Corporation | Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors |
MX2023000056A (en) | 2020-07-02 | 2023-04-12 | Incyte Corp | Tricyclic urea compounds as jak2 v617f inhibitors. |
WO2022006456A1 (en) | 2020-07-02 | 2022-01-06 | Incyte Corporation | Tricyclic pyridone compounds as jak2 v617f inhibitors |
US11661422B2 (en) | 2020-08-27 | 2023-05-30 | Incyte Corporation | Tricyclic urea compounds as JAK2 V617F inhibitors |
WO2022140231A1 (en) | 2020-12-21 | 2022-06-30 | Incyte Corporation | Deazaguaine compounds as jak2 v617f inhibitors |
TW202302589A (en) | 2021-02-25 | 2023-01-16 | 美商英塞特公司 | Spirocyclic lactams as jak2 v617f inhibitors |
CA3237199A1 (en) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
EP2181996A1 (en) * | 2002-01-29 | 2010-05-05 | Glaxo Group Limited | Aminopiperidine derivatives |
AR040335A1 (en) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | CYCLLOHEXAN OR CYCLHEXENE COMPOUND, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE AND INTERMEDIATE COMPOUNDS OF UTILITY TO PREPARE SUCH COMPOUND |
CA2500320A1 (en) * | 2002-10-10 | 2004-04-29 | Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie | Novel compounds with antibacterial activity |
DE10256405A1 (en) * | 2002-12-02 | 2004-06-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
DE10247233A1 (en) * | 2002-10-10 | 2004-06-17 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
AR042486A1 (en) * | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | QUINOLINE AND NAFTIRIDINE COMPOSITE HALOSUSTITUDED IN POSITION 3, PROCEDURE TO PREPARE THE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE SUCH COMPOSITION. |
-
2004
- 2004-08-25 DE DE102004041163A patent/DE102004041163A1/en not_active Withdrawn
-
2005
- 2005-08-25 MX MX2007002097A patent/MX2007002097A/en not_active Application Discontinuation
- 2005-08-25 KR KR1020067026765A patent/KR20070045152A/en not_active Application Discontinuation
- 2005-08-25 AU AU2005276576A patent/AU2005276576A1/en not_active Abandoned
- 2005-08-25 JP JP2007528748A patent/JP2008510762A/en not_active Withdrawn
- 2005-08-25 US US11/660,894 patent/US20070244103A1/en not_active Abandoned
- 2005-08-25 CA CA002571132A patent/CA2571132A1/en not_active Abandoned
- 2005-08-25 RU RU2007105995/04A patent/RU2410386C2/en not_active IP Right Cessation
- 2005-08-25 BR BRPI0514665-8A patent/BRPI0514665A2/en not_active IP Right Cessation
- 2005-08-25 NZ NZ552036A patent/NZ552036A/en not_active IP Right Cessation
- 2005-08-25 CN CNA200580028501XA patent/CN101035785A/en active Pending
- 2005-08-25 EP EP05787944A patent/EP1781650A1/en not_active Withdrawn
- 2005-08-25 WO PCT/EP2005/009204 patent/WO2006021448A1/en active Application Filing
-
2006
- 2006-12-05 IL IL179837A patent/IL179837A0/en unknown
Non-Patent Citations (1)
Title |
---|
TERENT'EW; GURWITSCH. SB.STATEI OBSHCH.KHIM, 1953, p.404-407 PROFFT; BIEDERMANN. J.PRAKT. CHEM, vol.15, 1962, p 54-61. * |
Also Published As
Publication number | Publication date |
---|---|
NZ552036A (en) | 2010-08-27 |
MX2007002097A (en) | 2007-04-24 |
US20070244103A1 (en) | 2007-10-18 |
DE102004041163A1 (en) | 2006-03-02 |
BRPI0514665A2 (en) | 2009-03-24 |
CA2571132A1 (en) | 2006-03-02 |
KR20070045152A (en) | 2007-05-02 |
JP2008510762A (en) | 2008-04-10 |
AU2005276576A1 (en) | 2006-03-02 |
CN101035785A (en) | 2007-09-12 |
RU2007105995A (en) | 2008-10-10 |
WO2006021448A1 (en) | 2006-03-02 |
IL179837A0 (en) | 2007-05-15 |
EP1781650A1 (en) | 2007-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2410386C2 (en) | Novel compounds possessing antibacterial activity | |
RU2403258C2 (en) | Thiazolyldihydroindazoles | |
RU2327701C2 (en) | Nucleoside derivatives and pharmaceutical composition, with antiviral activity to hcv | |
HUP0401889A2 (en) | 1,8-naphthyridine derivatives as antidiabetics and pharmaceutical compositions containing them | |
MXPA06011194A (en) | Thiadiazolidinones as gsk-3 inhibitors. | |
BRPI0509377A (en) | alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1 receptor antagonists | |
EA200600225A1 (en) | DERIVATIVES OF PIPERAZINE FOR THE TREATMENT OF HIV INFECTIONS | |
EP1609798A4 (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
CY1107422T1 (en) | FURAZANOBENZIMIDAZOLES | |
CA2634005A1 (en) | N-hydroxyamide derivatives possessing antibacterial activity | |
MY145031A (en) | N-(aminoheteroaryl)-1h-indole-2carboxamide derivatives, and preparation and therapeutic application thereof | |
JP2007246474A5 (en) | ||
HUP0500457A2 (en) | Polyalkylene polymer compounds, compositions containing the same and uses thereof | |
SE0302192D0 (en) | Novel compounds | |
TW200621694A (en) | Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds | |
RU2019122815A (en) | HISTONACETYLASE INHIBITORS | |
CA2441309A1 (en) | Biguanide derivatives | |
JP2000026494A5 (en) | ||
WO2006021833A3 (en) | Bisbenzamidines for the treatment of pneumonia | |
MA28325A1 (en) | NOVEL PHENYLPYRIDINYLPIPERAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
NO323556B1 (en) | Compounds, pharmaceutical compositions comprising the compounds, and the use of the compounds in the preparation of antibacterial drugs. | |
RU2004130284A (en) | ANTI-PARASITIC ARTEMISININ DERIVATIVES (ENDOPEROXIDES) | |
IL169577A0 (en) | Oligosaccharide derivatives and pharmaceutical compostions containing the same | |
PT1175429E (en) | HALO 9-DEOXO-9A-AZA-9A-HOMOERITHROMYCIN A HALO DERIVATIVES | |
RU2002118708A (en) | HETEROCYCLIC DERIVATIVES AND MEDICINES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110826 |